Profit

Hold Dr Reddy's Lab: IndiaNivesh Securities

PUBLISHED ON: November 26, 2015 | Duration: 15 min, 21 sec

  
loading..
Daljeet Kohli, head of research at IndiaNivesh Securities, told NDTV that Dr Reddy's shares were over-owned by the market which led to selloff in the stock. The recent correction in the stock has already factored in the worst-case scenario on account of US FDA warning.
ALSO WATCH
RIL Target Price May Be Revised Higher To Rs 1500: Daljeet Kohli

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com